CytoDyn Appoints David Feigal, M.D., as Chief Medical Officer
Published: Oct 28, 2013
CytoDyn Inc. (“CytoDyn”) (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced the appointment of Dr. David Feigal as the Company’s new Chief Medical Officer.
Help employers find you! Check out all the jobs and post your resume.